Copyright Reports & Markets. All rights reserved.

Global Primary Antibody Market Research Report 2021

Request for Sample of this report
Buy now

1 Primary Antibody Market Overview

  • 1.1 Product Overview and Scope of Primary Antibody
  • 1.2 Primary Antibody Segment by Type
    • 1.2.1 Global Primary Antibody Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Monoclonal Antibodies
    • 1.2.3 Polyclonal Antibody
  • 1.3 Primary Antibody Segment by Application
    • 1.3.1 Global Primary Antibody Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Life Sciences
    • 1.3.4 Laboratory
  • 1.4 Global Primary Antibody Market Size Estimates and Forecasts
    • 1.4.1 Global Primary Antibody Revenue 2016-2027
    • 1.4.2 Global Primary Antibody Sales 2016-2027
    • 1.4.3 Primary Antibody Market Size by Region: 2016 Versus 2021 Versus 2027

2 Primary Antibody Market Competition by Manufacturers

  • 2.1 Global Primary Antibody Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Primary Antibody Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Primary Antibody Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Primary Antibody Manufacturing Sites, Area Served, Product Type
  • 2.5 Primary Antibody Market Competitive Situation and Trends
    • 2.5.1 Primary Antibody Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Primary Antibody Players Market Share by Revenue
    • 2.5.3 Global Primary Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Primary Antibody Retrospective Market Scenario by Region

  • 3.1 Global Primary Antibody Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Primary Antibody Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Primary Antibody Market Facts & Figures by Country
    • 3.3.1 North America Primary Antibody Sales by Country
    • 3.3.2 North America Primary Antibody Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Primary Antibody Market Facts & Figures by Country
    • 3.4.1 Europe Primary Antibody Sales by Country
    • 3.4.2 Europe Primary Antibody Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Primary Antibody Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Primary Antibody Sales by Region
    • 3.5.2 Asia Pacific Primary Antibody Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Primary Antibody Market Facts & Figures by Country
    • 3.6.1 Latin America Primary Antibody Sales by Country
    • 3.6.2 Latin America Primary Antibody Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Primary Antibody Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Primary Antibody Sales by Country
    • 3.7.2 Middle East and Africa Primary Antibody Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Primary Antibody Historic Market Analysis by Type

  • 4.1 Global Primary Antibody Sales Market Share by Type (2016-2021)
  • 4.2 Global Primary Antibody Revenue Market Share by Type (2016-2021)
  • 4.3 Global Primary Antibody Price by Type (2016-2021)

5 Global Primary Antibody Historic Market Analysis by Application

  • 5.1 Global Primary Antibody Sales Market Share by Application (2016-2021)
  • 5.2 Global Primary Antibody Revenue Market Share by Application (2016-2021)
  • 5.3 Global Primary Antibody Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Bio-Rad
    • 6.1.1 Bio-Rad Corporation Information
    • 6.1.2 Bio-Rad Description and Business Overview
    • 6.1.3 Bio-Rad Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Bio-Rad Primary Antibody Product Portfolio
    • 6.1.5 Bio-Rad Recent Developments/Updates
  • 6.2 Biorbyt
    • 6.2.1 Biorbyt Corporation Information
    • 6.2.2 Biorbyt Description and Business Overview
    • 6.2.3 Biorbyt Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Biorbyt Primary Antibody Product Portfolio
    • 6.2.5 Biorbyt Recent Developments/Updates
  • 6.3 Abcam
    • 6.3.1 Abcam Corporation Information
    • 6.3.2 Abcam Description and Business Overview
    • 6.3.3 Abcam Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Abcam Primary Antibody Product Portfolio
    • 6.3.5 Abcam Recent Developments/Updates
  • 6.4 Thermo Fisher Scientific
    • 6.4.1 Thermo Fisher Scientific Corporation Information
    • 6.4.2 Thermo Fisher Scientific Description and Business Overview
    • 6.4.3 Thermo Fisher Scientific Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Thermo Fisher Scientific Primary Antibody Product Portfolio
    • 6.4.5 Thermo Fisher Scientific Recent Developments/Updates
  • 6.5 Creative Diagnostics
    • 6.5.1 Creative Diagnostics Corporation Information
    • 6.5.2 Creative Diagnostics Description and Business Overview
    • 6.5.3 Creative Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Creative Diagnostics Primary Antibody Product Portfolio
    • 6.5.5 Creative Diagnostics Recent Developments/Updates
  • 6.6 Novus Biologicals
    • 6.6.1 Novus Biologicals Corporation Information
    • 6.6.2 Novus Biologicals Description and Business Overview
    • 6.6.3 Novus Biologicals Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Novus Biologicals Primary Antibody Product Portfolio
    • 6.6.5 Novus Biologicals Recent Developments/Updates
  • 6.7 SouthernBiotech
    • 6.6.1 SouthernBiotech Corporation Information
    • 6.6.2 SouthernBiotech Description and Business Overview
    • 6.6.3 SouthernBiotech Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 SouthernBiotech Primary Antibody Product Portfolio
    • 6.7.5 SouthernBiotech Recent Developments/Updates
  • 6.8 Boster Bio
    • 6.8.1 Boster Bio Corporation Information
    • 6.8.2 Boster Bio Description and Business Overview
    • 6.8.3 Boster Bio Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Boster Bio Primary Antibody Product Portfolio
    • 6.8.5 Boster Bio Recent Developments/Updates
  • 6.9 OriGene
    • 6.9.1 OriGene Corporation Information
    • 6.9.2 OriGene Description and Business Overview
    • 6.9.3 OriGene Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 OriGene Primary Antibody Product Portfolio
    • 6.9.5 OriGene Recent Developments/Updates
  • 6.10 Genscript Biotech
    • 6.10.1 Genscript Biotech Corporation Information
    • 6.10.2 Genscript Biotech Description and Business Overview
    • 6.10.3 Genscript Biotech Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Genscript Biotech Primary Antibody Product Portfolio
    • 6.10.5 Genscript Biotech Recent Developments/Updates
  • 6.11 Proteintech
    • 6.11.1 Proteintech Corporation Information
    • 6.11.2 Proteintech Primary Antibody Description and Business Overview
    • 6.11.3 Proteintech Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Proteintech Primary Antibody Product Portfolio
    • 6.11.5 Proteintech Recent Developments/Updates
  • 6.12 Roche Diagnostics
    • 6.12.1 Roche Diagnostics Corporation Information
    • 6.12.2 Roche Diagnostics Primary Antibody Description and Business Overview
    • 6.12.3 Roche Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Roche Diagnostics Primary Antibody Product Portfolio
    • 6.12.5 Roche Diagnostics Recent Developments/Updates
  • 6.13 HyTest
    • 6.13.1 HyTest Corporation Information
    • 6.13.2 HyTest Primary Antibody Description and Business Overview
    • 6.13.3 HyTest Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 HyTest Primary Antibody Product Portfolio
    • 6.13.5 HyTest Recent Developments/Updates

7 Primary Antibody Manufacturing Cost Analysis

  • 7.1 Primary Antibody Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Primary Antibody
  • 7.4 Primary Antibody Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Primary Antibody Distributors List
  • 8.3 Primary Antibody Customers

9 Primary Antibody Market Dynamics

  • 9.1 Primary Antibody Industry Trends
  • 9.2 Primary Antibody Growth Drivers
  • 9.3 Primary Antibody Market Challenges
  • 9.4 Primary Antibody Market Restraints

10 Global Market Forecast

  • 10.1 Primary Antibody Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Primary Antibody by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Primary Antibody by Type (2022-2027)
  • 10.2 Primary Antibody Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Primary Antibody by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Primary Antibody by Application (2022-2027)
  • 10.3 Primary Antibody Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Primary Antibody by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Primary Antibody by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Monoclonal Antibodies
    Polyclonal Antibody

    Segment by Application
    Hospital
    Life Sciences
    Laboratory

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Bio-Rad
    Biorbyt
    Abcam
    Thermo Fisher Scientific
    Creative Diagnostics
    Novus Biologicals
    SouthernBiotech
    Boster Bio
    OriGene
    Genscript Biotech
    Proteintech
    Roche Diagnostics
    HyTest

    Buy now